# Black Seed Oil Blood Pressure Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/black-seed-oil-blood-pressure-meta-analysis-evidence-review
Category: evidence-review
Summary: Black Seed Oil Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass
Last reviewed: 2026-05-20
Reviewed by: Migaku Evidence Review
# Black Seed Oil Blood Pressure Meta-analysis: What the Evidence Says

## Quick Answer

Black Seed Oil Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| The Effect of Nigella sativa Supplementation on Cardiometabolic Health in Patients With Metabolic Diseases: A GRADE ‐Assessed Systematic Review and Meta‐Analysis | systematic review | 1 | 2026-03-20 | 10.1002/edm2.70207 |
| Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy | preclinical study | 4 | 2026-01-01 | 10.7150/ijms.123717 |

## What The Sources Report

- These conditions do not operate in isolation; they directly promote atherosclerosis and cardiovascular damage by exacerbating a cluster of intermediate, modifiable cardiovascular risk factors. [Musazadeh Vali (2026); evidence level 1]
- This cluster includes hypertension, dysglycemia (elevated fasting glucose and HbA1c), insulin resistance, and adverse body composition (e.g., increased central adiposity). [Musazadeh Vali (2026); evidence level 1]
- Dietary approaches are considered a key component in the prevention and management of cardiometabolic risk factors. [Kuo Wu-Hsien (2026); evidence level 4]
- In addition to its effects on traditional cardiometabolic risk factors, emerging findings from animal and cellular models suggest that sesame supplementation may exert biological effects relevant to retinopathy, a common microvascular complication of metabolic disorders, particularly diabetes,. [Kuo Wu-Hsien (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For black seed oil blood pressure meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Musazadeh Vali (2026). The Effect of
Nigella sativa
Supplementation on Cardiometabolic Health in Patients With Metabolic Diseases: A GRADE ‐Assessed Systematic Review and Meta‐Analysis. DOI: 10.1002/edm2.70207. PMCID: PMC13093553. PMID: 41858302. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13093553/
- Kuo Wu-Hsien (2026). Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. DOI: 10.7150/ijms.123717. PMCID: PMC12964580. PMID: 41799776. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12964580/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.